Avrobio | Nettoeinkommen

Net Income Veränderung Datum
Adcock Ingram Holdings ZAR 430.06M 38.29M 2023-06
Alnylam Pharmaceuticals USD -65935000 71.94M 2024-03
Celltrion KRW 1.89B 836.87M 2024-03
Cspc Pharmaceutical CNY 1.38B 159.46M 2023-12
Dianthus Therapeutics USD -13748000 3.18M 2024-03
Ecofibre AUD -22305000 4.7M 2023-06
Gilead Sciences USD -4170000000 5.6B 2024-03
Ionis Pharmaceuticals USD -142803000 133.54M 2024-03
Kangmei Pharma CNY 7.47M 29.62M 2024-03
Knight Therapeutics CAD -4546000 19.78M 2024-03
Laboratorios Farma EUR 14.96M 88.73M 2024-03
MacroGenics USD -52190000 6.12M 2024-03
Malin Corporation EUR 1.1M 10.6M 2023-06
Medical Developments International AUD -8267000 10.92M 2023-06
Neuren Pharmaceuticals AUD 47.8M 40.57M 2023-06
Organigram Holdings CAD -27075000 11.32M 2024-03
Pfizer USD 3.12B 6.48B 2024-03
Pharma Mar EUR 2.3M 9.12M 2024-03
Probiotec AUD 5.56M 96.63K 2023-06
Qiagen NV USD 80.67M 16.99M 2024-03
Roche Holding CHF 7.14B 3.25B 2023-06
Sanofi EUR 1.13B 1.39B 2024-03
Sarepta Therapeutics USD 36.12M 77.06M 2024-03
Sartorius EUR 36.7M 28.4M 2024-03
Sino Biopharmaceutical CNY 1.26B 636.25M 2023-06
Takeda JPY 105.72B 153.75B 2023-12
Tilray USD -92701000 43.69M 2024-02
Zz Pientze Pharmaceu 863.81M 92.66M 2023-09



Avrobio Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2024.